Department of Medical Imaging, Radboud University Nijmegen Medical Centre, Geert Grooteplein 10, 6525 GA, Nijmegen, Gelderland, The Netherlands.
Department of Interventional Radiology, Shamir Medical Center (Assaf Harofeh), 70300, Zerifin, Israel.
Curr Oncol Rep. 2022 Nov;24(11):1433-1441. doi: 10.1007/s11912-022-01291-3. Epub 2022 Jun 7.
Minimal invasive procedures, including targeted biopsy (TB) and focal therapy (FT), are increasingly used in diagnosis and treatment of localized prostate cancer. Here, we review the current role of these procedures, from a perspective of an interventional radiologist.
TB is an established part of current guidelines for diagnosis of PCa. Several modalities of FT are gaining prevalence in recent years, as a tissue-preserving alternative for definitive treatment of localized PCa. FT is currently at early research stages, offered to selected patients in clinical trials settings. TB and FT are minimally invasive procedures used by multidisciplinary teams for diagnosis and treatment of localized PCa.
微创介入技术,包括靶向活检(TB)和局灶治疗(FT),越来越多地用于局限性前列腺癌的诊断和治疗。本文从介入放射医师的角度,综述了这些技术的作用。
TB 是当前前列腺癌诊断指南的既定组成部分。近年来,随着作为局限性前列腺癌确定性治疗的组织保留替代方法,多种 FT 方式越来越流行。FT 目前处于早期研究阶段,在临床试验环境中提供给特定患者。TB 和 FT 是多学科团队用于诊断和治疗局限性前列腺癌的微创介入技术。